• GKT137831: Dual NADPH Oxidase Nox1/Nox4 Inhibitor in Redox R

  2026-04-25

  GKT137831 empowers researchers to dissect oxidative stress mechanisms with precision, uniquely modulating Nox1/Nox4-driven ROS in fibrosis, vascular remodeling, and advanced cell signaling assays. Explore protocol optimization, troubleshooting, and cross-study workflows leveraging APExBIO's trusted reagent.

• Formononetin Prevents Oxaliplatin-Induced Neurotoxicity via

  2026-04-24

  This study demonstrates that formononetin activates the Nrf2/HO-1 antioxidant pathway to protect neurons from oxaliplatin-induced peripheral neurotoxicity without compromising its anticancer efficacy. The work addresses a critical gap in chemotherapy-induced peripheral neuropathy research, highlighting a promising strategy for preserving neuronal health during cancer treatment.

• Pazopanib (GW-786034): Applied Workflows for Cancer Research

  2026-04-24

  Pazopanib (GW-786034) empowers cancer researchers with highly selective, multi-targeted receptor tyrosine kinase inhibition, enabling precise angiogenesis and tumor growth studies. This article details actionable protocols, advanced applications, and troubleshooting insights—especially for ATRX-deficient glioma models—making it an indispensable tool in the translational oncology lab.

• SMYD2 Inhibition Mitigates Cisplatin-Induced Renal Fibrosis

  2026-04-23

  This study demonstrates that pharmacological SMYD2 inhibition, using agents such as LLY-507, significantly protects against cisplatin-induced renal fibrosis and inflammation. By elucidating SMYD2's mechanistic role in chronic kidney disease, the findings offer new avenues for epigenetic intervention in fibrosis and highlight translational opportunities for targeted therapies.

• Gastrin I (human): Precision Modulation of Gastric Acid in O

  2026-04-23

  Explore how human Gastrin I peptide advances gastric acid secretion pathway research using organoid models. This article offers a mechanistic deep-dive, protocol parameters, and practical insights distinct from existing literature.

• TAK-715: Precision p38 MAPK Inhibitor for Inflammation Resea

  2026-04-22

  TAK-715 stands out as a potent, selective p38 MAPK inhibitor, enabling high-fidelity dissection of cytokine-driven inflammatory pathways. Its dual-action mechanism and advanced conformational targeting, as validated by recent structural biology, empower researchers to achieve reproducible and translatable results in both cell-based and in vivo models.

• Strategic Use of YC-1 for Translational Hypoxia Research

  2026-04-22

  This article delivers a mechanistically grounded, evidence-forward perspective on YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol as a dual-action tool for translational cancer and hypoxia research. Framing current bottlenecks in hypoxia signaling and tumor microenvironment studies, we dissect how YC-1’s distinct molecular actions—HIF-1α inhibition and sGC activation—address both mechanistic and workflow challenges. By integrating evidence from recent literature and advanced protocols, we provide actionable guidance for translational researchers, while situating APExBIO’s YC-1 as an enabling reagent for next-generation experimental design.

• Abiraterone Acetate: Potent CYP17 Inhibitor for Prostate Can

  2026-04-21

  Abiraterone acetate is a high-potency CYP17 inhibitor and a key tool in castration-resistant prostate cancer (CRPC) research. It acts as a 3β-acetate prodrug with superior solubility and irreversible enzyme inhibition. APExBIO provides validated, high-purity Abiraterone acetate (A8202) for robust mechanistic and translational studies.

• 7ACC2: Monocarboxylate Transporter 1 Inhibitor for Cancer Me

  2026-04-21

  7ACC2 is a dual-action monocarboxylate transporter 1 inhibitor that uniquely blocks both lactate and mitochondrial pyruvate transport, enabling high-precision dissection of cancer metabolism and immunometabolic crosstalk. Optimized for robust antitumor and radiosensitizing effects, 7ACC2 empowers advanced experimental workflows targeting metabolic vulnerabilities in tumor models.

• Butylated Hydroxyanisole (BHA): Optimizing Oxidative Stress

  2026-04-20

  Butylated hydroxyanisole (BHA) stands out as a high-purity synthetic antioxidant, unlocking precision and reproducibility in oxidative stress and reactive oxygen species (ROS) detection assays. This guide details advanced experimental workflows, protocol-specific optimizations, and troubleshooting strategies that empower researchers to maximize the impact of BHA in redox and apoptosis pathway studies.

• Triacetin’s Role in Enhancing Aldehyde Formation in E-Cigare

  2026-04-20

  This study uniquely demonstrates that triacetin, widely used as a flavoring and solvent in e-cigarette liquids, significantly increases the formation of toxic aldehydes during aerosolization. By employing isotopic labeling and NMR analysis, the authors provide mechanistic insights relevant to inhalation toxicology and formulation science.

• EZ Cap™ Firefly Luciferase mRNA: Optimizing Delivery & Assay

  2026-04-19

  Explore how EZ Cap™ Firefly Luciferase mRNA enables superior mRNA delivery and translation efficiency assays. This article uniquely dissects redox modulation strategies and integration with advanced lipid nanoparticle systems, offering new insights for molecular biology researchers.

• Cyclic Pifithrin-α hydrobromide: Precision p53 Inhibition In

  2026-04-18

  Cyclic Pifithrin-α hydrobromide is a selective p53 inhibitor used to modulate apoptosis and DNA damage responses in cell models. Its ability to distinguish p53-dependent from p53-independent processes makes it invaluable in cancer and radioprotection research. This article synthesizes mechanistic, benchmark, and workflow evidence for research applications.

• Molecular Mechanisms of Fruit Abscission in Actinidia arguta

  2026-04-17

  Yuan et al. dissect the hormonal and transcriptional networks underlying physiological fruit abscission in Actinidia arguta by combining comparative transcriptomics with transient genetic transformation. Their findings clarify how auxin and ethylene interplay, and reveal candidate genes and pathways for breeding cultivars with reduced fruit drop.

• IDP-Inspired Nanovectors Enable Efficient Cytosolic mRNA Del

  2026-04-16

  Jin et al. introduce intrinsically disordered protein (IDP)-inspired nanovectors (IDP-NVs) capable of forming stable nanocoacervates (NCs) for direct cytosolic delivery of diverse biomacromolecules, including mRNA. By mimicking the flexibility and phase-separation properties of membraneless organelles, these nanovectors overcome key delivery barriers and enable efficient, transporter-free internalization. This innovation has significant implications for mRNA delivery and functional reporter assays in molecular biology.

14455 records 1/964 page Next 12345 下5页 Last page